Dirk Hoffmann
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Immune cells in cancer
Papers in
-
- CRISPR and Genetic Engineering 13
- RNA Interference and Gene Delivery 9
- Pluripotent Stem Cells Research 6
- Advanced biosensing and bioanalysis techniques 3
- Glycosylation and Glycoproteins Research 2
- Genetics 13
- Virus-based gene therapy research 10
- Co-authors
- Axel Schambach (25 shared papers)Thomas Moritz (5 shared papers)Doris Steinemann (8 shared papers)Nico Lachmann (5 shared papers)Mania Ackermann (3 shared papers)Joachim Hauber (2 shared papers)Michael Schindler (2 shared papers)Carina Banning (2 shared papers)
- Journals
- Stem Cell Reports (4 papers)Gene Therapy (3 papers)Human Gene Therapy (3 papers)Molecular Therapy (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Dirk Hoffmann
28 papers receiving 799 citations
Peers
Comparison fields: 5 of 90
- Virology 47
- Immunology 173
- Molecular Biology 495
- Genetics 193
- Oncology 134
Countries citing papers authored by Dirk Hoffmann
This map shows the geographic impact of Dirk Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hoffmann more than expected).
Fields of papers citing papers by Dirk Hoffmann
This network shows the impact of papers produced by Dirk Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hoffmann. The network helps show where Dirk Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 152 | |
| 2 | 2010 | 129 | |
| 3 | 2015 | 59 | |
| 4 | 2017 | 43 | |
| 5 | 2016 | 43 | |
| 6 | 2019 | 37 | |
| 7 | 2019 | 31 | |
| 8 | 2013 | 31 | |
| 9 | 2006 | 30 | |
| 10 | 2019 | 26 | |
| 11 | 2019 | 25 | |
| 12 | 2014 | 20 | |
| 13 | 2012 | 20 | |
| 14 | 2016 | 20 | |
| 15 | 2018 | 17 | |
| 16 | 2017 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2020 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2014 | 11 |
About Dirk Hoffmann
Dirk Hoffmann is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Hematology, having authored 28 papers that have together received 815 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (9 papers), Pluripotent Stem Cells Research (6 papers), CAR-T cell therapy research (3 papers), Acute Myeloid Leukemia Research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Virology (47 citations), Immunology (173 citations), Molecular Biology (495 citations), Genetics (193 citations) and Oncology (134 citations). Dirk Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Axel Schambach, Thomas Moritz, Doris Steinemann, Nico Lachmann, Mania Ackermann, Joachim Hauber, Michael Schindler, Carina Banning, Michael Morgan and Frank Kirchhoff. Their work appears in journals such as Stem Cell Reports, Gene Therapy, Human Gene Therapy, Molecular Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.